Conditional lineage ablation to model human diseases

Paul Lee, Gregory Morley, Qian Huang, Avi Fischer, Stephanie Seiler, James W. Horner, Stephen Factor, Dhananjay Vaidya, José Jalife, Glenn I. Fishman

Research output: Contribution to journalArticle

Abstract

Cell loss contributes to the pathogenesis of many inherited and acquired human diseases. We have developed a system to conditionally ablate cells of any lineage and developmental stage in the mouse by regulated expression of the diphtheria toxin A (DTA) gene by using tetracycline-responsive promoters. As an example of this approach, we targeted expression of DTA to the hearts of adult mice to model structural abnormalities commonly observed in human cardiomyopathies. Induction of DTA expression resulted in cell loss, fibrosis, and chamber dilatation. As in many human cardiomyopathies, transgenic mice developed spontaneous arrhythmias in vivo, and programmed electrical stimulation of isolated-perfused transgenic hearts demonstrated a strikingly high incidence of spontaneous and inducible ventricular tachycardia. Affected mice showed marked perturbations of cardiac gap junction channel expression and localization, including a subset with disorganized epicardial activation patterns as revealed by optical action potential mapping. These studies provide important insights into mechanisms of arrhythmogenesis and suggest that conditional lineage ablation may have wide applicability for studies of disease pathogenesis.

Original languageEnglish (US)
Pages (from-to)11371-11376
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number19
DOIs
StatePublished - Sep 15 1998
Externally publishedYes

Fingerprint

Diphtheria Toxin
Cardiomyopathies
Voltage-Sensitive Dye Imaging
Gap Junctions
Structural Models
Cell Lineage
Ventricular Tachycardia
Tetracycline
Transgenic Mice
Electric Stimulation
Cardiac Arrhythmias
Dilatation
Fibrosis
Incidence
Genes

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Lee, P., Morley, G., Huang, Q., Fischer, A., Seiler, S., Horner, J. W., ... Fishman, G. I. (1998). Conditional lineage ablation to model human diseases. Proceedings of the National Academy of Sciences of the United States of America, 95(19), 11371-11376. https://doi.org/10.1073/pnas.95.19.11371

Conditional lineage ablation to model human diseases. / Lee, Paul; Morley, Gregory; Huang, Qian; Fischer, Avi; Seiler, Stephanie; Horner, James W.; Factor, Stephen; Vaidya, Dhananjay; Jalife, José; Fishman, Glenn I.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 19, 15.09.1998, p. 11371-11376.

Research output: Contribution to journalArticle

Lee, P, Morley, G, Huang, Q, Fischer, A, Seiler, S, Horner, JW, Factor, S, Vaidya, D, Jalife, J & Fishman, GI 1998, 'Conditional lineage ablation to model human diseases', Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 19, pp. 11371-11376. https://doi.org/10.1073/pnas.95.19.11371
Lee, Paul ; Morley, Gregory ; Huang, Qian ; Fischer, Avi ; Seiler, Stephanie ; Horner, James W. ; Factor, Stephen ; Vaidya, Dhananjay ; Jalife, José ; Fishman, Glenn I. / Conditional lineage ablation to model human diseases. In: Proceedings of the National Academy of Sciences of the United States of America. 1998 ; Vol. 95, No. 19. pp. 11371-11376.
@article{78b106571a324a5e9e318a52f921a1b1,
title = "Conditional lineage ablation to model human diseases",
abstract = "Cell loss contributes to the pathogenesis of many inherited and acquired human diseases. We have developed a system to conditionally ablate cells of any lineage and developmental stage in the mouse by regulated expression of the diphtheria toxin A (DTA) gene by using tetracycline-responsive promoters. As an example of this approach, we targeted expression of DTA to the hearts of adult mice to model structural abnormalities commonly observed in human cardiomyopathies. Induction of DTA expression resulted in cell loss, fibrosis, and chamber dilatation. As in many human cardiomyopathies, transgenic mice developed spontaneous arrhythmias in vivo, and programmed electrical stimulation of isolated-perfused transgenic hearts demonstrated a strikingly high incidence of spontaneous and inducible ventricular tachycardia. Affected mice showed marked perturbations of cardiac gap junction channel expression and localization, including a subset with disorganized epicardial activation patterns as revealed by optical action potential mapping. These studies provide important insights into mechanisms of arrhythmogenesis and suggest that conditional lineage ablation may have wide applicability for studies of disease pathogenesis.",
author = "Paul Lee and Gregory Morley and Qian Huang and Avi Fischer and Stephanie Seiler and Horner, {James W.} and Stephen Factor and Dhananjay Vaidya and Jos{\'e} Jalife and Fishman, {Glenn I.}",
year = "1998",
month = "9",
day = "15",
doi = "10.1073/pnas.95.19.11371",
language = "English (US)",
volume = "95",
pages = "11371--11376",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - Conditional lineage ablation to model human diseases

AU - Lee, Paul

AU - Morley, Gregory

AU - Huang, Qian

AU - Fischer, Avi

AU - Seiler, Stephanie

AU - Horner, James W.

AU - Factor, Stephen

AU - Vaidya, Dhananjay

AU - Jalife, José

AU - Fishman, Glenn I.

PY - 1998/9/15

Y1 - 1998/9/15

N2 - Cell loss contributes to the pathogenesis of many inherited and acquired human diseases. We have developed a system to conditionally ablate cells of any lineage and developmental stage in the mouse by regulated expression of the diphtheria toxin A (DTA) gene by using tetracycline-responsive promoters. As an example of this approach, we targeted expression of DTA to the hearts of adult mice to model structural abnormalities commonly observed in human cardiomyopathies. Induction of DTA expression resulted in cell loss, fibrosis, and chamber dilatation. As in many human cardiomyopathies, transgenic mice developed spontaneous arrhythmias in vivo, and programmed electrical stimulation of isolated-perfused transgenic hearts demonstrated a strikingly high incidence of spontaneous and inducible ventricular tachycardia. Affected mice showed marked perturbations of cardiac gap junction channel expression and localization, including a subset with disorganized epicardial activation patterns as revealed by optical action potential mapping. These studies provide important insights into mechanisms of arrhythmogenesis and suggest that conditional lineage ablation may have wide applicability for studies of disease pathogenesis.

AB - Cell loss contributes to the pathogenesis of many inherited and acquired human diseases. We have developed a system to conditionally ablate cells of any lineage and developmental stage in the mouse by regulated expression of the diphtheria toxin A (DTA) gene by using tetracycline-responsive promoters. As an example of this approach, we targeted expression of DTA to the hearts of adult mice to model structural abnormalities commonly observed in human cardiomyopathies. Induction of DTA expression resulted in cell loss, fibrosis, and chamber dilatation. As in many human cardiomyopathies, transgenic mice developed spontaneous arrhythmias in vivo, and programmed electrical stimulation of isolated-perfused transgenic hearts demonstrated a strikingly high incidence of spontaneous and inducible ventricular tachycardia. Affected mice showed marked perturbations of cardiac gap junction channel expression and localization, including a subset with disorganized epicardial activation patterns as revealed by optical action potential mapping. These studies provide important insights into mechanisms of arrhythmogenesis and suggest that conditional lineage ablation may have wide applicability for studies of disease pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=13144275262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13144275262&partnerID=8YFLogxK

U2 - 10.1073/pnas.95.19.11371

DO - 10.1073/pnas.95.19.11371

M3 - Article

VL - 95

SP - 11371

EP - 11376

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -